Search
-
Know the New America & Beyond: July 2026
A monthly dispatch of Ipsos’ best insights on the U.S., tailored for the world.
-
Global attitudes towards refugees remain stable, while questions about implementation persist
Research released by Ipsos in partnership with UNHCR, the UN Refugee Agency, during the 75th anniversary of the 1951 Refugee Convention.
-
Why Oncologists Are Prescribing GLP-1s
When cancer specialists embrace – and when they avoid – this revolutionary drug class.
-
Continued appetite for investment in infrastructure alongside pragmatism to improve outcomes
The 2026 Global Infrastructure Index from Ipsos and the Global Infrastructure Investor Association (GIIA).
-
Beyond the Step Change: What GLP-1s Solved - and What They Didn’t
GLP-1 therapies have redefined what obesity pharmacotherapy can achieve, but efficacy is no longer the only battleground.
-
The Ipsos Energy Transition Barometer
In the 2026 Energy Transition Barometer, we look at how affordability, security, and reliability concerns are converging to reshape public support for the energy transition across 31 countries — including a rare before-and-after view of attitudes following the Iran conflict.
-
Ipsos Update – July 2026
Football, Pride, Digital Twins… Ipsos Update explores the latest research and thinking on key topics from Ipsos teams around the world.
-
Know the New America & Beyond: June 2026
A monthly dispatch of Ipsos’ best insights on the U.S., tailored for the world
-
Beyond the Claim: The Case for Direct-to-Responder RWE in U.S. Healthcare
The U.S. healthcare claims system is a reputable source of secondary real-world data, but what happens when the patient falls out of the system?